Aldeyra Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.637; its P/E ratio is -6.05; Aldeyra Therapeutics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $-0.11. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -4.24M	$ -7.65M	$ -8.46M	$ -15.12M	$ -13.70M
EBITDA	$ -4.10M	$ -7.49M	$ -8.30M	$ -14.98M	-
Net Income Common Stockholders	$ -4.75M	$ -8.19M	$ -8.99M	$ -15.62M	$ -12.90M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 29.88M
Total Assets	$ 148.33M	$ 147.28M	$ 155.62M	$ 168.21M	$ 181.27M
Total Debt	$ 15.66M	$ 16.18M	$ 16.15M	$ 16.11M	$ 16.08M
Net Debt	$ 15.66M	$ 16.18M	$ 16.15M	$ 16.11M	$ -13.80M
Total Liabilities	$ 28.53M	$ 24.27M	$ 25.73M	$ 30.98M	$ 181.29M
Stockholders Equity	$ 119.80M	$ 123.01M	$ 129.88M	$ 137.24M	$ 151.01M
Cash Flow	-
Free Cash Flow	$ 500.44K	$ -8.02M	$ -13.36M	$ -9.44M	$ -11.23M
Operating Cash Flow	$ 500.44K	$ -8.02M	$ -13.36M	$ -9.44M	$ -11.23M
Investing Cash Flow	-	-	-	$ 30.00M	$ 27.00M
Financing Cash Flow	$ -1.01M	$ -315.76K	$ 5.29K	$ 52.56K	-

Currency in USD

Aldeyra Therapeutics Earnings and Revenue History

Income Statement >

Aldeyra Therapeutics Debt to Assets

Balance Sheet >

Aldeyra Therapeutics Cash Flow

Cash Flow >

Aldeyra Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing